C-MER Medical announced on February 1 that the company has entered into a non-legally binding letter of intent with a potential strategic partner operating in mainland China, which includes businesses such as optical lens design and development, licensing introduction, and distribution. The company’s designated subsidiary intends to acquire a controlling stake in the strategic partner’s subsidiary that operates in lens technology development and distribution.

